# Evaluation of the Clinical and Immunological Impact of Two Therapeutic Strategies in Chronic Inflammatory Diseases

> **NCT03370601** · NA · TERMINATED · sponsor: **University Hospital, Lille** · enrollment: 9 (actual)

## Conditions studied

- Inflammatory Bowel Diseases

## Interventions

- **DRUG:** Infliximab
- **DRUG:** Mercaptopurine
- **DRUG:** Azathioprine
- **DRUG:** Infliximab

## Key facts

- **NCT ID:** NCT03370601
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-01-03
- **Primary completion:** 2019-01
- **Final completion:** 2019-01
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Not enough recruitment Lack of funding CR
- **Last updated:** 2019-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03370601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03370601, "Evaluation of the Clinical and Immunological Impact of Two Therapeutic Strategies in Chronic Inflammatory Diseases". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03370601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*